Literature DB >> 23189617

[The role of microRNAs in the pathogenesis of cervical cancer and its relationship to HPV].

Yao-Kui Zhu1, Ni Cheng, Ying Hu, Ying-Zhou Cen.   

Abstract

A lot of miRNAs have participated in the regulation of numerous biological processes such as cell proliferation, apoptosis, invasion and migration in cervical cancer, and closely associated with prognosis and susceptibility of cervical cancer. The oncogenic proteins E6, E7 and E5 expressed by HPV directly or indirectly lead to the dysregulation of multiple miRNAs such as miR-34a,miR-218, miR-29a and miR-146a, subsequently contribute to the initiation and progression of cervical cancer. In turn, some miRNAs such as miR-203 and miR-125b also play roles in the regulation of HPV DNA duplication. In addition, the latest advances on miRNA basic research and its potential significance in the diagnosis and treatment of malignant tumors are also reviewed in this paper.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23189617

Source DB:  PubMed          Journal:  Sheng Li Ke Xue Jin Zhan        ISSN: 0559-7765


  4 in total

1.  HPV 16 E7 inhibits OSCC cell proliferation, invasion, and metastasis by upregulating the expression of miR-20a.

Authors:  Jun Hu; Weili Ge; Junfeng Xu
Journal:  Tumour Biol       Date:  2016-01-19

2.  Elevated serum level of microRNA (miRNA)-200c and miRNA-371-5p in children with Kawasaki disease.

Authors:  Ki Wook Yun; Ji Young Lee; Sin Weon Yun; In Seok Lim; Eung Sang Choi
Journal:  Pediatr Cardiol       Date:  2013-11-21       Impact factor: 1.655

3.  MicroRNA-130a regulated by HPV18 E6 promotes proliferation and invasion of cervical cancer cells by targeting TIMP2.

Authors:  Shanlan Yin; Quanle Zhang; Yuhong Wang; Shaoru Li; Ruili Hu
Journal:  Exp Ther Med       Date:  2019-01-31       Impact factor: 2.447

Review 4.  Non-Coding RNAs: Strategy for Viruses' Offensive.

Authors:  Alessia Gallo; Matteo Bulati; Vitale Miceli; Nicola Amodio; Pier Giulio Conaldi
Journal:  Noncoding RNA       Date:  2020-09-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.